ULTRALIFE CORP — Director's Dealing 2021

Oct 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2021-10-20

Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-20	Common Stock (Right to Buy)	$6.9694	A	40000	Acquired	2028-10-20	Common Stock (40000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock; $.10 par value	309926	Direct

Footnotes

F1: These options vest as follows: 13,334 shares on 10-20-2022; 13,333 shares vest on 10-20-2023 and 13,333 shares vest on 10-20-2024.